Promising New Drug Shines Light On Cancer Cure
(Washington, DC) -- A recently developed drug is shining new light on a possible cure for cancer. The drug, named lodamin, was developed using nanotechnology and a fungus that contaminated a lab experiment. The late cancer researcher Dr. Judah Folkman founded the idea of starving tumors by preventing them from growing blood supplies. It was Harvard's Donald Ingber who accidently stumbled upon a fungus that appeared to prevent the growth of capillary blood vessels. For 20 years, Folkman's team worked on the drug, which comes in pill form and has no known side-effects. It proved successful in treating breast cancer, neuroblastoma, ovarian cancer, prostate cancer, brain tumors and uterine tumors in lab mice. The researchers say the drug could also be effective in treating other diseases marked by abnormal blood vessel growth such as age-related macular degeneration. |